Study reveals low adoption of recommended smart inhaler therapy for asthma

FHS
May 22, 2024
3:51 am

Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40 percent of academic pulmonary and allergy clinicians have not adopted this optimal therapy, according to research published at the ATS 2024 International Conference.

3DHISTECH launches the new flagship P480 2nd Generation, powered with polarization

3DHISTECH unveils its latest flagship product, the P480 2nd Gen. Leveraging a decade of research and diagnostic excellence established by the P480, the P480 2nd

September 23, 2024

Cooper scraps $875M takeover of Cook Medical business after FTC investigation

Dive Brief: CooperCompanies has terminated its $875 million takeover of Cook Medical’s reproductive health business, the Federal Trade Commission said in a Tuesday statement. The

August 2, 2023

Prepare now to use convalescent plasma for the next pandemic

The global medical community encountered a highly contagious aerosolized pathogen with no known treatment when the SARS-CoV 2-virus triggered the Covid-19 global pandemic nearly five

December 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.